£147.93

Convalescent Plasma and Other Antibody Therapies for Infectious Diseases: Lessons learned from COVID-19 and Future Prospects: 443 (Current Topics in Microbiology and Immunology, 443)

Name: Convalescent Plasma and Other Antibody Therapies for Infectious Diseases: Lessons learned from COVID-19 and Future Prospects: 443 (Current Topics in Microbiology and Immunology, 443)
Brand: Unknown
Price: 147.93 GBP
Availability: InStock

Diseases & Disorders

Price data last checked 78 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 13 days • 13 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 13 days • 1 price levels

Days at Price

Price Analysis

Most common price: £148 (13 days, 100.0%)

Price range: £148 - £148

Price levels: 1 different prices over 13 days

Description

This volume reviews key scientific principles and practices of passive antibody therapy for the treatment of infectious diseases. The main focus is on convalescent plasma, which is the most useful therapeutic option early in an epidemic, and may be especially important in low- and middle-income countries. The book’s first section reviews the history of passive antibody therapies prior to the COVID pandemic, while the second section assesses convalescent plasma use during the COVID pandemic including evidence for safety and effectiveness, factors affecting efficacy, and the importance of convalescent plasma treatment of COVID-19 infections in the immunosuppressed. This section also addresses the roles played in the pandemic by monoclonal antibodies and hyperimmune globulins. Section three discusses the logistics of retrieving, storing and delivering convalescent plasma for therapy, and section four considers the role of passive antibody therapies in the event of a new pandemic involving an unknown microbial pathogen. In March 2020 the editors of this volume founded the national COVID-19 convalescent plasma project (ccpp19), an association of academic physicians organized to investigate the safety and effectiveness of convalescent plasma and to facilitate access to its use in the treatment of this new international pandemic. Since that time, the project has produced more than 100 papers on almost every aspect of convalescent plasma usage in COVID-19 – treatment protocols, randomized trials, considerations of safety, conditions required for effectiveness, variability in use geographically and over time, application to vulnerable populations, regulatory issues, impact on overall COVID-19 mortality in the US and much else. At the same time, another form of antibody therapy – monoclonal antibodies – was being shown effective for out-patient use in COVID-19, confirming the principle of the value of antibody therapy in the early stages of disease, but lost effectiveness with viral mutation. A third form of antibody therapy – hyperimmune globulin, a preventive therapy with an excellent historical record of efficacy in several infectious diseases - holds great potential but was not effectively developed for COVID-19. This edited work brings together the central findings gained over the past years about passive antibody use and serves as an indispensable guide to best practices in the use of antibody therapies.

Product Specifications

Format: hardcover
ASIN: 3031871669
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 17 October 2025
Listed Since: 07 February 2025

Barcode

No barcode data available

Convalescent Plasma and Other Antibody Therapies for Infectious Diseases: Lessons learned from COVID-19 and Future Prospects: 443 (Current Topics in Microbiology and Immunology, 443)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19, An Issue of the Clinics in Laboratory Medicine: Volume 42-1 (The Clinics: Internal Medicine, Volume 42-1)

Springer Complement Therapeutics: 735 - Medical Research Book

Coronavirus Disease 2019 (Covid-19): A Clinical Guide

Identification of Biomarkers, New Treatments, and Vaccines for COVID-19: 1327 (Advances in Experimental Medicine and Biology, 1327)

Immunomodulators and Combinatorial Approaches to Tackle Klebsiella

Fc Mediated Activity of Antibodies: Structural and Functional Diversity: 423 (Current Topics in Microbiology and Immunology, 423)

COVID-19: The Essentials of Prevention and Treatment

Elsevier Mandell, Douglas & Bennett's Infectious Diseases 2-Volume Set

Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination (Volume 1) (Future of Autoimmunity Research, Volume 1)

Clinical Immunology: Principles and Practice

How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)

How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)

Common Questions: Infectious Diseases in the Community Setting (Common Questions in ID)

Advances in Microbiology, Infectious Diseases and Public Health: Volume 1: 897 (Advances in Experimental Medicine and Biology, 897)

Vaccination Strategies Against Highly Variable Pathogens: 428 (Current Topics in Microbiology and Immunology, 428)

Vaccination Strategies Against Highly Variable Pathogens: 428 (Current Topics in Microbiology and Immunology, 428)

Covid-19: Biomedical Perspectives (Volume 50) (Methods in Microbiology, Volume 50)

Clinical, Biological and Molecular Aspects of COVID-19: Includes Digital Download: 1321 (Advances in Experimental Medicine and Biology, 1321)

Human Challenge Studies for Vaccine Development: 445 (Current Topics in Microbiology and Immunology, 445)

Advances in Microbiology, Infectious Diseases and Public Health 2

Springer Inflammasome Signaling and Bacterial Infections 397

COVID-19: Tackling Global Pandemics through Scientific and Social Tools

Human Monoclonal Antibodies: Methods and Protocols: 1904 (Methods in Molecular Biology, 1904)

Clinical Management of Pediatric COVID-19: An International Perspective and Practical Guide